(Q40143351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Irene V Bijnsdorp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jaap van den Berg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gitta K Kuipers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Laurine E Wedekind

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Johannes van Rijn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Vincent M Lafleur

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Peter Sminia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

20 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

25-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

Current approaches to radiation therapy for malignant gliomas

29 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9385-4

Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9385-4

Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9385-4

Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse

21 January 2018

1 reference

12 December 2020

Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.

1 reference

12 December 2020

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations

1 reference

12 December 2020

Properties of human malignant glioma cells in vitro

1 reference

12 December 2020

Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma

1 reference

12 December 2020

Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

1 reference

12 December 2020

D-1 dopaminergic and beta-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM.

1 reference

12 December 2020

Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.

1 reference

12 December 2020

Cyclooxygenase in the treatment of glioma: its complex role in signal transduction

1 reference

12 December 2020

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice

1 reference

12 December 2020

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

12 December 2020

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

1 reference

12 December 2020

Differential effect of 9 beta-chloro-16, 16-dimethyl prostaglandin E2 (nocloprost) on the radiation response of human normal fibroblasts and colon adenocarcinoma cells

1 reference

12 December 2020

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism

1 reference

12 December 2020

Comparison of in vivo murine intestinal radiation protection by E-prostaglandins

1 reference

12 December 2020

Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.

1 reference

12 December 2020

Increase in radioresponse of murine tumors by treatment with indomethacin

1 reference

12 December 2020

In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells

1 reference

12 December 2020

Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.

1 reference

12 December 2020

Mismatch repair proficiency is not required for radioenhancement by gemcitabine.

1 reference

12 December 2020

Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib

1 reference

12 December 2020

Meloxicam inhibits the growth of non-small cell lung cancer

1 reference

12 December 2020

Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells

1 reference

12 December 2020

X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells

1 reference

12 December 2020

COX-2 inhibitors act as radiosensitizer in tumor treatment.

1 reference

12 December 2020

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations

1 reference

12 December 2020

Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth

1 reference

12 December 2020

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

1 reference

12 December 2020

Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N-nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters

1 reference

12 December 2020

Regression of hepatocellular carcinoma due to cyclooxygenase (COX)-2 inhibitor

1 reference

12 December 2020

Cyclooxygenase-2: a novel target for cancer chemotherapy?

1 reference

12 December 2020

Meloxicam inhibits the growth of colorectal cancer cells

1 reference

12 December 2020

NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2.

1 reference

12 December 2020

Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.

1 reference

12 December 2020

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

12 December 2020

Cyclooxygenase-2 expression in human esophageal carcinoma

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor

1 reference

12 December 2020

10.1007/S11060-007-9385-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17447009%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 December 2019

1050366113

0 references

1 reference